2
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Achievement of IOP Target Among a Sample of Iraqi Patients with Glaucoma: A Retrospective Study

&
Pages 2107-2112 | Received 18 May 2024, Accepted 02 Jul 2024, Published online: 23 Jul 2024

References

  • Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–1911. doi:10.1001/jama.2014.3192
  • Martucci A, Nucci C, Pinazo-Duran MD. New perspectives in glaucoma pathophysiology, diagnosis, and treatment. Front Med. 2023;10:1200427. doi:10.3389/fmed.2023.1200427
  • Mahdi H, El Abbadi N. Glaucoma diagnosis based on retinal fundus image: a review. Iraqi J Sci. 2022;4022–4046. doi:10.24996/ijs.2022.63.9.32
  • Harasymowycz P, Birt C, Gooi P, et al. Medical management of glaucoma in the 21st century from a Canadian perspective. J Ophthalmol. 2016;2016:1–22. doi:10.1155/2016/6509809
  • Hussein HA, Bunian WS, Abd Saadoon A. Epidemiology of ophthalmological disease in outpatient clinic In AL-Nasiriya during 2018. Univ Thi-Qar J Med. 2019;18(2):54–67.
  • Allison K, Patel D, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020;12(11). doi:10.7759/cureus.11686
  • Torabi R, Harris A, Siesky B, et al. Prevalence rates and risk factors for primary open angle glaucoma in the Middle East. J Ophthalmic Vis Res. 2021;16(4):644. doi:10.18502/jovr.v16i4.9755
  • Abdulsahib WK, Al-Zubaidy A, Sahib HB, Kathem SH. Tolerable ocular hypotensive effect of topically applied sildenafil in ocular in normotensive and betamethasone-induced hypertensive rabbits. Int J Pharm Sci Rev Res. 2015;35(1):96–102.
  • Atey TM, Shibeshi W, Giorgis TA, Asgedom SW. The impact of adherence and instillation proficiency of topical glaucoma medications on intraocular pressure. J Ophthalmol. 2017;2017:1–8. doi:10.1155/2017/1683430
  • Razooki RA, Saeed EN, Al-Deem HIO. Microbial contamination of eye drops in out patient in Iraq. Iraqi J Pharm Sci. 2011;20:91–95.
  • Warjri GB, Sidhu T, Kishan A, et al. Achieving low target intraocular pressures in severe glaucoma. Eur J Ophthalmol. 2021;31(6):3068–3073. doi:10.1177/1120672120979903
  • Sihota R, Angmo D, Ramaswamy D, Dada T. Simplifying “target” intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma. Indian J Ophthalmol. 2018;66(4):495. doi:10.4103/ijo.IJO_1130_17
  • Lindén C, Heijl A, Jóhannesson G, Aspberg J, Andersson Geimer S, Bengtsson B. Initial intraocular pressure reduction by mono‐versus multi‐therapy in patients with open‐angle glaucoma: results from the Glaucoma Intensive Treatment Study. Acta Ophthalmol. 2018;96(6):567–572. doi:10.1111/aos.13790
  • DiPiro JT, DiPiro CV, Schwinghammer TL, Wells BG. Pharmacotherapy Handbook. McGraw-hill; 2015.
  • Sun Y, Chen A, Zou M, et al. Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the global burden of disease study 2017. BMJ Open. 2022;12(1):e053805. doi:10.1136/bmjopen-2021-053805
  • Laroche D, Capellan P. The aging lens and glaucoma in persons over 50: why early cataract surgery/refractive lensectomy and microinvasive trabecular bypass can prevent blindness and cure elevated eye pressure. J Natl Med Asso. 2021;113(4):471–473. doi:10.1016/j.jnma.2021.03.001
  • Laroche D, Rickford K, Mike EV, et al. A novel, low‐cost glaucoma calculator to identify glaucoma patients and stratify management. J Ophthalmol. 2022;2022(1):5288726. doi:10.1155/2022/5288726
  • Jeong D, Sung KR, Na JH. Comparison of clinical characteristics and progression rates of bilaterally and unilaterally progressing glaucoma. Korean j Ophthalmol. 2015;29(1):40–46. doi:10.3341/kjo.2015.29.1.40
  • Al-Yaqubi ON, Momjian RLB, Bader MM. the value of color Doppler imaging in patients with primary open angle asymmetric glaucoma. J Fac Med Baghdad. 2005;47(4).
  • Yu L, Ding K, Luo L, Yu Z. Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017. PLoS One. 2020;15(1):e0227595.
  • Hosoda M, Yamabayashi S, Furuta M, Tsukahara S. Do glaucoma patients use eye drops correctly? J Glaucoma. 1995;4(3):202–206. doi:10.1097/00061198-199506000-00011
  • Covert D, Robin AL. Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost. Curr Med Res Opin. 2006;22(5):971–976. doi:10.1185/030079906X104777
  • Movahedinejad T, Adib-Hajbaghery M. Adherence to treatment in patients with open-angle glaucoma and its related factors. Electron Physician. 2016;8(9):2954. doi:10.19082/2954
  • Saif AT, Saif P. Achieving Target IOP. Glokom-Katarakt. 2017;12(1):60–69.
  • Al‐Ganmi AHA, Alotaibi A, Gholizadeh L, Perry L. Medication adherence and predictive factors in patients with cardiovascular disease: a cross‐sectional study. Nurs Health Sci. 2020;22(2):454–463. doi:10.1111/nhs.12681
  • Al-Tuma A, Jassim NA. Adherence to methotrexate in Iraqi patients with rheumatoid arthritis: a cross-sectional stuDY. Glob J Public Health Med. 2022;4(1):618–630.
  • Johnson TV, Toris CB, Fan S, Camras CB. Effects of central corneal thickness on the efficacy of topical ocular hypotensive medications. J Glaucoma. 2008;17(2):89–99. PMID: 18344753. doi:10.1097/IJG.0b013e31814b9938
  • Vida RG, Merczel S, Jáhn E, Fittler A. Developing a framework regarding a complex risk based methodology in the evaluation of hazards associated with medicinal products sourced via the internet. Saudi Pharm J. 2020;28(12):1733–1742. doi:10.1016/j.jsps.2020.10.018
  • Al-Jumaili AA, Younus MM, Saleh MZ. The epidemic of substandard and falsified medications in Iraq: evaluating the effectiveness of national pharmacovigilance alerts to community pharmacies. Pharmaceut Med. 2021;35(3):169–186. doi:10.1007/s40290-021-00386-9
  • Traverso CE Practical points on the target IOP, Glaucoma World No. 19; 2000.
  • Salh HJH, Hussein TA, Aziz TA. Highlighting the Issues associated with glaucoma medication therapy: a pharmaceutical care evaluation. Al-Rafidain J Med Sci. 2023;5:57–66. doi:10.54133/ajms.v5i.149